Atopic Dermatitis - The Dermatology Digest

NEA to Hold Capitol Hill Policy Summit to Reform Step Therapy, Reduce Prior Authorization Burdens

October 8, 2025

U.S. FDA Approves Roflumilast Cream 0.05% for AD in Kids Aged 2 to 5

October 6, 2025

Targeting IL-22 in AD: A Q&A About LEO Pharma’s Temtokibart With Michael Ardern-Jones

October 1, 2025

TDD News Brief: Nevisense Can Detect Skin Barrier Dysfunction in AD

September 26, 2025

AD Pipeline Watch: Bambusa’s BBT001 Advances to Patient Dosing

September 25, 2025

Tralokinumab (Adbry, LEO Pharma) in AD: Reviewing New Data From the ECZTRA 3 and ECZTEND Trials With Dr. Andy Blauvelt

September 24, 2025

Advertisement

Advertisement

Latest Issue

Latest Supplements

Upcoming Conferences

Advertisement

Advertisement

Digital Edition Archive